logo-mobile
  • About
    ▼
    • Mission
    • Technology
    • Team
    • Investors
  • Technology
    ▼
    • Technology Story
    • How It Works
    • Targeted Impact
    • Applications
  • Pipeline
    ▼
    • Development
    • Pipeline Objectives
    • Featured Publications
  • News
    ▼
    • Press Releases
    • Media Coverage
    • Events
  • Logo
  • Partners
  • Careers
    ▼
    • Open Positions
  • Contact
    ▼
    • Legal
  • Search
  • About
    • Mission
    • Technology
    • Team
    • Investors
  • Technology
    • Technology Story
    • How It Works
    • Targeted Impact
    • Applications
  • Pipeline
    • Development
    • Pipeline Objectives
    • Featured Publications
  • News
    • Press Releases
    • Media Coverage
    • Events
  • Logo
  • Partners
  • Careers
    • Open Positions
  • Contact
    • Legal
  • Search

how can we help?

Archives: Media Coverages

Cybrexa is Selected as a Digital RESI September Innovation Challenge Winner

Cybrexa is proud to be selected as one of three Digital RESI September Innovation Challenge Winners (from 24 finalists)!
Thank you RESI for the honor!

Innovation Challenge

 

Cybrexa Wins 2020 CT Entrepreneurship Awards (Venture, Pre-Revenue)

https://drive.google.com/file/d/1BqsaVuf0ulhFnCW_KVlaMA6l99EI_3XC/view

Cybrexa CEO Per Hellsund Featured on BioBoss Podcast

https://bioboss.buzzsprout.com/236855/4700270-24-per-hellsund-co-founder-and-ceo-of-cybrexa

Cybrexa Named as ‘One to Watch’ in Nature’s The Spinoff Prize 2020

Very proud that the accomplishments of our team were recognized when Cybrexa was named a “one to watch“ in the #TheSpinoffPrize competition launched by @nature and @merckgroup

https://www.nature.com/articles/d41586-020-01904-6

New Arsenal in the Battle Against Cancer: Pharmaceutical Smart Bombs Promise Less Collateral Damage for Patients

https://podcasts.apple.com/ch/podcast/episode-2-cell-penetrating-peptides-for-cancer-treatment/id1520348819?i=1000480069727

 

CSO Vishwas Paralkar Talks alphalex and Tumor Targeting in Drug Development & Delivery

NEXT-GENERATION TUMOR TARGETING – Leveraging the Tumor Microenvironment to Change the Standard of Care

Cybrexa Therapeutics CEO Per Hellsund Featured in PharmaVOICE ‘The Future of Decentralized Trials’

The Future of Decentralized Trials

Cybrexa CEO Per Hellsund named in New Haven Biz ‘Power 50’

https://www.newhavenbiz.com/edition/2020-03-01

Cybrexa CEO Per Hellsund Provides Perspective on Innovation and Leadership

Bioscience Entrepreneur on Innovation, Team-Building, and How His Company Stood Out in a Crowded Field

 

Cybrexa’s CEO and Scientific Co-Founder With Personal Missions to Fight Cancer Featured in New Haven Biz

https://www.newhavenbiz.com/article/some-of-new-havens-leading-scientists-and-biotech-industry-leaders-are-on-a-personal

Posts navigation

Page 1 Page 2 Page 3 Next page

Recent Comments

    Archives

    Categories

    • Board of directors
    • Management Team
    • Scientific Advisors

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    about

    about

    • Mission
    • technology
    • team

    Technology

    Technology

    • technology story
    • targeted impact
    • how it works
    • applications

    pipeline

    pipeline

    • Development
    • Pipeline Objectives
    • Featured Publications

    news

    news

    • press releases
    • media coverage
    • events

    partners

    partners

    careers

    careers

    • open positions

    Contact us

    • legal

    © 2018 Cybrexa | All Rights Reserved